AAPL334.51+2.24 (+0.67%) ▲|ABBV261.43+4.31 (+1.68%) ▲|ABT102.95+1.00 (+0.98%) ▲|ACN194.28+10.38 (+5.64%) ▲|ADBE264.86+12.63 (+5.01%) ▲|AMAT426.96-29.53 (-6.47%) ▼|AMD494.09-22.05 (-4.27%) ▼|AMGN380.37+3.02 (+0.80%) ▲|AMT177.20-0.65 (-0.37%) ▼|AMZN255.59-1.19 (-0.46%) ▼|AVGO346.64-15.36 (-4.24%) ▼|AXP326.91+2.22 (+0.68%) ▲|BA210.37-0.09 (-0.04%) ▼|BAC60.11-2.59 (-4.12%) ▼|BKNG175.20+1.28 (+0.74%) ▲|BLK1,066.89-12.76 (-1.18%) ▼|BMY64.12+0.48 (+0.75%) ▲|BNY158.30-4.36 (-2.68%) ▼|BRK-B513.81+3.44 (+0.67%) ▲|C133.83-4.99 (-3.59%) ▼|CAT786.08-32.50 (-3.97%) ▼|CL88.34+1.54 (+1.77%) ▲|CMCSA24.98-0.22 (-0.87%) ▼|COF207.37-0.94 (-0.45%) ▼|COP137.69+0.34 (+0.25%) ▲|COST917.05+12.28 (+1.36%) ▲|CRM258.90+11.18 (+4.51%) ▲|CSCO111.49-0.65 (-0.58%) ▼|CVS95.67+1.01 (+1.07%) ▲|CVX213.68-0.39 (-0.18%) ▼|DE681.39+5.65 (+0.84%) ▲|DHR203.41+3.27 (+1.63%) ▲|DIS109.18+2.63 (+2.47%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.37-3.82 (-2.51%) ▼|FDX311.61+0.84 (+0.27%) ▲|GD356.78+0.88 (+0.25%) ▲|GE317.29-6.38 (-1.97%) ▼|GEV873.25-84.02 (-8.78%) ▼|GILD145.74+2.02 (+1.41%) ▲|GM86.41+0.79 (+0.92%) ▲|GOOG345.45+10.00 (+2.98%) ▲|GOOGL348.92+10.42 (+3.08%) ▲|GS990.42-38.76 (-3.77%) ▼|HD310.54+1.80 (+0.58%) ▲|HON199.12-3.25 (-1.60%) ▼|IBM250.89+7.60 (+3.12%) ▲|INTC98.29-4.66 (-4.52%) ▼|INTU338.38+16.81 (+5.23%) ▲|ISRG376.21+7.06 (+1.91%) ▲|JNJ267.88+2.30 (+0.87%) ▲|JPM349.21-7.02 (-1.97%) ▼|KO89.14+0.85 (+0.96%) ▲|LIN464.53-1.70 (-0.36%) ▼|LLY1,145.82+30.12 (+2.70%) ▲|LMT527.84+3.65 (+0.70%) ▲|LOW198.37+1.55 (+0.79%) ▲|LRCX275.82-22.41 (-7.51%) ▼|MA575.04+5.85 (+1.03%) ▲|MCD257.19+4.66 (+1.85%) ▲|MDLZ62.38-0.06 (-0.10%) ▼|MDT93.31+2.35 (+2.58%) ▲|META664.45+16.42 (+2.53%) ▲|MMM162.01-2.96 (-1.79%) ▼|MO70.55+1.57 (+2.27%) ▲|MRK145.46+1.53 (+1.06%) ▲|MS207.18-7.21 (-3.36%) ▼|MSFT509.20+13.57 (+2.74%) ▲|MU926.10-49.17 (-5.04%) ▼|NEE82.21-0.10 (-0.12%) ▼|NFLX80.75+3.35 (+4.32%) ▲|NKE37.15+0.35 (+0.94%) ▲|NOW143.13+10.60 (+7.99%) ▲|NVDA212.42-5.88 (-2.69%) ▼|ORCL143.85-6.44 (-4.28%) ▼|PEP136.61+0.29 (+0.21%) ▲|PFE27.78+0.06 (+0.20%) ▲|PG146.24+0.97 (+0.67%) ▲|PLTR173.30+6.07 (+3.63%) ▲|PM193.93+2.87 (+1.50%) ▲|QCOM179.12-2.85 (-1.57%) ▼|RTX194.66-3.03 (-1.53%) ▼|SBUX98.86+0.12 (+0.12%) ▲|SCHW106.98-0.27 (-0.25%) ▼|SO86.85-0.33 (-0.37%) ▼|SPG204.76-0.08 (-0.04%) ▼|T26.44+0.38 (+1.46%) ▲|TMO612.15+2.33 (+0.38%) ▲|TMUS183.99+1.66 (+0.91%) ▲|TSLA362.69-2.75 (-0.75%) ▼|TXN264.64-4.06 (-1.51%) ▼|UBER72.76+1.09 (+1.52%) ▲|UNH384.33+7.56 (+2.01%) ▲|UNP284.54+0.14 (+0.05%) ▲|UPS101.69+1.41 (+1.41%) ▲|USB62.38-0.46 (-0.73%) ▼|V376.34+5.89 (+1.59%) ▲|VZ51.30+0.69 (+1.35%) ▲|WFC87.69-2.60 (-2.88%) ▼|WMT109.49+2.34 (+2.18%) ▲|XOM165.46-0.54 (-0.32%) ▼|AAPL334.51+2.24 (+0.67%) ▲|ABBV261.43+4.31 (+1.68%) ▲|ABT102.95+1.00 (+0.98%) ▲|ACN194.28+10.38 (+5.64%) ▲|ADBE264.86+12.63 (+5.01%) ▲|AMAT426.96-29.53 (-6.47%) ▼|AMD494.09-22.05 (-4.27%) ▼|AMGN380.37+3.02 (+0.80%) ▲|AMT177.20-0.65 (-0.37%) ▼|AMZN255.59-1.19 (-0.46%) ▼|AVGO346.64-15.36 (-4.24%) ▼|AXP326.91+2.22 (+0.68%) ▲|BA210.37-0.09 (-0.04%) ▼|BAC60.11-2.59 (-4.12%) ▼|BKNG175.20+1.28 (+0.74%) ▲|BLK1,066.89-12.76 (-1.18%) ▼|BMY64.12+0.48 (+0.75%) ▲|BNY158.30-4.36 (-2.68%) ▼|BRK-B513.81+3.44 (+0.67%) ▲|C133.83-4.99 (-3.59%) ▼|CAT786.08-32.50 (-3.97%) ▼|CL88.34+1.54 (+1.77%) ▲|CMCSA24.98-0.22 (-0.87%) ▼|COF207.37-0.94 (-0.45%) ▼|COP137.69+0.34 (+0.25%) ▲|COST917.05+12.28 (+1.36%) ▲|CRM258.90+11.18 (+4.51%) ▲|CSCO111.49-0.65 (-0.58%) ▼|CVS95.67+1.01 (+1.07%) ▲|CVX213.68-0.39 (-0.18%) ▼|DE681.39+5.65 (+0.84%) ▲|DHR203.41+3.27 (+1.63%) ▲|DIS109.18+2.63 (+2.47%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.37-3.82 (-2.51%) ▼|FDX311.61+0.84 (+0.27%) ▲|GD356.78+0.88 (+0.25%) ▲|GE317.29-6.38 (-1.97%) ▼|GEV873.25-84.02 (-8.78%) ▼|GILD145.74+2.02 (+1.41%) ▲|GM86.41+0.79 (+0.92%) ▲|GOOG345.45+10.00 (+2.98%) ▲|GOOGL348.92+10.42 (+3.08%) ▲|GS990.42-38.76 (-3.77%) ▼|HD310.54+1.80 (+0.58%) ▲|HON199.12-3.25 (-1.60%) ▼|IBM250.89+7.60 (+3.12%) ▲|INTC98.29-4.66 (-4.52%) ▼|INTU338.38+16.81 (+5.23%) ▲|ISRG376.21+7.06 (+1.91%) ▲|JNJ267.88+2.30 (+0.87%) ▲|JPM349.21-7.02 (-1.97%) ▼|KO89.14+0.85 (+0.96%) ▲|LIN464.53-1.70 (-0.36%) ▼|LLY1,145.82+30.12 (+2.70%) ▲|LMT527.84+3.65 (+0.70%) ▲|LOW198.37+1.55 (+0.79%) ▲|LRCX275.82-22.41 (-7.51%) ▼|MA575.04+5.85 (+1.03%) ▲|MCD257.19+4.66 (+1.85%) ▲|MDLZ62.38-0.06 (-0.10%) ▼|MDT93.31+2.35 (+2.58%) ▲|META664.45+16.42 (+2.53%) ▲|MMM162.01-2.96 (-1.79%) ▼|MO70.55+1.57 (+2.27%) ▲|MRK145.46+1.53 (+1.06%) ▲|MS207.18-7.21 (-3.36%) ▼|MSFT509.20+13.57 (+2.74%) ▲|MU926.10-49.17 (-5.04%) ▼|NEE82.21-0.10 (-0.12%) ▼|NFLX80.75+3.35 (+4.32%) ▲|NKE37.15+0.35 (+0.94%) ▲|NOW143.13+10.60 (+7.99%) ▲|NVDA212.42-5.88 (-2.69%) ▼|ORCL143.85-6.44 (-4.28%) ▼|PEP136.61+0.29 (+0.21%) ▲|PFE27.78+0.06 (+0.20%) ▲|PG146.24+0.97 (+0.67%) ▲|PLTR173.30+6.07 (+3.63%) ▲|PM193.93+2.87 (+1.50%) ▲|QCOM179.12-2.85 (-1.57%) ▼|RTX194.66-3.03 (-1.53%) ▼|SBUX98.86+0.12 (+0.12%) ▲|SCHW106.98-0.27 (-0.25%) ▼|SO86.85-0.33 (-0.37%) ▼|SPG204.76-0.08 (-0.04%) ▼|T26.44+0.38 (+1.46%) ▲|TMO612.15+2.33 (+0.38%) ▲|TMUS183.99+1.66 (+0.91%) ▲|TSLA362.69-2.75 (-0.75%) ▼|TXN264.64-4.06 (-1.51%) ▼|UBER72.76+1.09 (+1.52%) ▲|UNH384.33+7.56 (+2.01%) ▲|UNP284.54+0.14 (+0.05%) ▲|UPS101.69+1.41 (+1.41%) ▲|USB62.38-0.46 (-0.73%) ▼|V376.34+5.89 (+1.59%) ▲|VZ51.30+0.69 (+1.35%) ▲|WFC87.69-2.60 (-2.88%) ▼|WMT109.49+2.34 (+2.18%) ▲|XOM165.46-0.54 (-0.32%) ▼|
22.2 C
New York
Monday, September 14, 2026

Tag: website

newssourceFORcompanyinformationcontent1releasesmarket

Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:

Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., June 6, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering,...

Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference

LEXINGTON, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced that Keros’ Chair and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in a fireside chat presentation at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 9:20 a.m. Eastern time.

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Company announcement – No. 14 / 2025

Silvano Fashion Group AS Consolidated Annual Report 2024

At its meeting held on 06 June 2025, the Supervisory Board of Silvano Fashion Group AS approved the annual report of Silvano Fashion Group AS for the financial year 2024 and for submission to the general meeting of shareholders. 

Subsplash Launches New Contactless Solution for Instant Church Giving, Engagement & Growth

DALLAS, June 6, 2025 /PRNewswire/ -- Church technology innovator Subsplash introduces Subsplash Tap, a contactless solution that transforms how church attendees connect, give, and...

Dr. Louis Krenn Medical Scholarship Invites Aspiring Physicians to Shape the Future of Healthcare

SPRINGFIELD, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- The Dr. Louis Krenn Medical Scholarship announces a new opportunity for undergraduate and medical students across the United States to advance their journey toward a career in medicine. This prestigious one-time award, established by Dr. Louis Krenn, a distinguished Family Medicine physician, aims to support the next generation of healthcare professionals who demonstrate a commitment to service, innovation, and compassion. The scholarship, open to students nationwide, invites applicants to share their vision for the future of medicine through a thought-provoking essay.

Decision Notice – CIRO Sanctions Jagdish Chandane

TORONTO, June 6, 2025 /CNW/ - On May 22, 2025, a hearing panel of the Canadian Investment Regulatory Organization (CIRO) held a hearing pursuant...

Toobit Wins Digital Asset Derivatives Platform of the Year at Hedgeweek Global Digital Assets Awards 2025

GEORGE TOWN, Cayman Islands, June 06, 2025 (GLOBE NEWSWIRE) -- Toobit, a leading global cryptocurrency exchange, today wins the title of Digital Asset Derivatives Platform of the Year at the Hedgeweek Global Digital Assets Awards 2025, announced during the Hedgeweek Digital Assets Summit Europe on June 5 at County Hall in London.

Atlas Door Repair Expands 24/7 Emergency Services to Serve Commercial Centers Across Illinois and Florida

Strategic multi-city expansion improves emergency response times and compliance for automatic and sliding doors in underserved regions PLAINFIELD, Ill. and LAKELAND, Fla. and INTERLACHEN, Fla.,...

ThinkMarkets to launch Traders’ Gym on its mobile app

LONDON, June 6, 2025 /PRNewswire/ -- ThinkMarkets, a global leader in online CFD trading, continues to strengthen its position in the industry by enhancing...

Spineway : Minutes of the General Meeting of June 4, 2025

Press release        

Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032

FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food and Drug Administration (FDA) has approved Phathom’s Citizen Petition filed on December 11, 2024 and communicated the Agency’s intention to correct the Orange Book to recognize the proper 10 years of New Chemical Entity exclusivity for VOQUEZNA® (vonoprazan) tablets, extending through May 3, 2032.

AI-Powered Vehicle Inspection Company iNeedaPPi Expands Across Canada, Offering Fast, Affordable, and Transparent Used Car Evaluations

TORONTO, June 6, 2025 /CNW/ -- iNeedaPPi Mobile Car Inspectors, a Canada-based company known for its technology-driven approach to used vehicle inspections, has expanded...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsWebsite

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers